Navigation Links
Soils offer new hope as carbon sink

The huge potential of agricultural soils to reduce greenhouse gases and increase production at the same time has been reinforced by new research findings at NSW Department of Primary Industries' (DPI) Wollongbar Agricultural Institute.

Trials of agrichar - a product hailed as a saviour of Australia's carbon-depleted soils and the environment - have doubled and, in one case, tripled crop growth when applied at the rate of 10 tonnes per hectare.

Agrichar is a black carbon byproduct of a process called pyrolysis, which involves heating green waste or other biomass without oxygen to generate renewable energy.

Tim Flannery, Australian of the Year and renowned scientist, conservationist, writer and explorer, is a major advocate of agrichar and pyrolysis.

In The Bulletin magazine, Flannery recently ranked "fostering pyrolysis-based technologies" fourth among his five steps for saving the planet, because they convert crop waste into fuel and agrichar which can be used to enhance soil fertility and store carbon long-term.

NSW DPI senior research scientist Dr Lukas Van Zwieten said soils naturally emit about 10 times more greenhouse gas on a global scale than the burning of fossil fuels.

"So it is not surprising there is so much interest in a technology to create clean energy that also locks up carbon in the soil for the long term and lifts agricultural production," he said.

The trials at Wollongbar have focused on the benefits of agrichar to agricultural productivity.

"When applied at 10t/ha, the biomass of wheat was tripled and of soybeans was more than doubled," said Dr Van Zwieten.

"This percentage increase remained the same when applications of nitrogen fertiliser were added to both the agrichar and the control plots.

"For the wheat, agrichar alone was about as beneficial for yields as using nitrogen fertiliser only. "And that is without considering the other benefits of
'"/>

Source:New South Wales Department of Primary Industries


Page: 1 2 3

Related biology news :

1. Ancient olfaction protein is shared by many bugs, offering new pest control target
2. Protein offers way to stop microscopic parasites in their tracks
3. Nanoparticles offer new hope for detection and treatment
4. Whats really making you sick? Plant pathologists offer the science behind Sick Building Syndrome
5. Gene silencing technique offers new strategy for treating, curing disease
6. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
7. Engineered skin offers clues to melanoma development
8. Flies on speed offer insight into the roles of dopamine in sleep and arousal
9. Neurotransmitters signal aggressive cancer, offer potential for early diagnosis
10. Study findings offer potential new targets for antibiotics
11. Dendritic cells offer new therapeutic target for drugs to treat MS and other autoimmune disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Soils offer new hope carbon sink

(Date:7/8/2008)...o stay fit, do their bit for the environment or av...eir health if they don,t choose the right bicycle....al surgeon Mr Vinod Nargund from St Bartholomew,s ...rnal BJU International . , He says that the pro...ection problems and soreness and skin irritations ...
(Date:7/8/2008)... . , Barcelona, Spain: Couples who need IVF... this will not lead to developmental problems in e...ual conference of the European Society of Human Re...Dr. Karin Middelburg, from the University Medical ... that the study, which looked at the quality of ge...
(Date:7/8/2008)... . , Barcelona, Spain: Children born after ...omb have higher birth weight than those born where...ed to the 24th annual conference of the European S...(Tuesday 8 July). The mothers had longer pregnanci...k of congenital malformations, said Dr. Anja Pinbo...
(Date:7/7/2008)...U.S. coral reef ecosystems are considered to be in...A analysis of the health of coral reefs under U.S....tate of Coral Reef Ecosystems of the United States...that the nation,s coral reef ecosystems, particula... face intense human-derived threats from coastal d...
Breaking Biology News(10 mins):Male cyclists risk sexual problems if they don’t choose the right bike 2IVF does not increase risk of developmental disorders in children 2Children born from frozen embryos weigh more and do better than those born after fresh transfer 2NOAA report states half of US coral reefs in 'poor' or 'fair' condition 2New insight into RA patient priorities and motivators for clinical trial involvement 21796 1New insight into RA patient priorities and motivators for clinical trial involvement 21796 2New insight into RA patient priorities and motivators for clinical trial involvement 21796 3Express Scripts in Binding Agreement with MSC for the Purchase of its Pharmacy Services Division 21792 1Express Scripts in Binding Agreement with MSC for the Purchase of its Pharmacy Services Division 21792 2Express Scripts in Binding Agreement with MSC for the Purchase of its Pharmacy Services Division 21792 3Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 1Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 2Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 3Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 4Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 5Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 6Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 7Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 8Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 9Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 10Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 11Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 12Video 3A Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5982 13Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 1Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 2Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 3Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 4Patients Taking Cymbalta 28R 29 Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study 2421 5
...at the Johns Hopkins Bloomberg School of Public He...r a variety of illnesses using genetically modifie...ctions. Oral adenovirus vaccines have long been pr...ieve their process for constructing a replicating ...nomical vaccines that provide longer-lasting disea...
...eport today in the journal Genome,Research that th...eviously intractable DNA sequence: a 554-kilobase-...man Y chromosome. This sequence,contains eight put...ex-associated height differences and gonadal tumor...f the few holes remaining in the,"finished" sequen...
...ave discovered that a protein that was originally ... resistance is actually a "missing enzyme" from th...cteria to scavenge iron. , The research appears as...he Journal of Biological Chemistry, an American So...al. , Mycobacterium tuberculosis, the causative a...
...pment in the analysis of cancer,has been announced... an,innovative method that enables the rapid advan... in cancer. According to the report,published in t...he,National Academy of Science (PNAS) in collabora...tute, Agilent has developed a specialised,microarr...
Other Biology News:Live Recombinant Adenovirus Vaccine Technique Explored 2Found: Missing sequence of the human Y chromosome 2Found: Missing sequence of the human Y chromosome 3Scientists find missing enzyme for tuberculosis iron scavenging pathway 2Breakthrough Microarray-based Technology for the Study of Cancer 2
(Date:7/8/2008)... BugLab LLC, has introduced the,BugEye 200 Noninva...system,with the widest linear range of any such de...ontinuous, real-time optical density (OD) measurem...applications. The BugEye 200,is designed for use i...ents,and has a sensor that is easily secured to th...
(Date:7/8/2008)...alization of the Revolutionary Ac...ch., July 8 /- Accuri Cytometers Inc.... bench-top flow cytometer systems,today announced...g led by,Fidelity Biosciences and Flagship Venture...ers and Arboretum Ventures also participated in th...
(Date:7/8/2008)... PAREXEL International,Corporation (Nasdaq: PRXL ...,financial results on Wednesday, August 6, 2008 af...t will be available on PAREXEL,s website at, http:...at http://www.prnewswire.com ., PAREXEL will ho.... EDT,on Thursday, August 7, 2008 to discuss the r...
(Date:7/8/2008)...- GeneGo, Inc., the leading,systems biology tools ...s,license to GeneGo products. Unilever uses system...s and skin care product development., "Unilever w...we are,very pleased to continue working with them,...opment. "Unilever is a consumer goods company that...
Breaking Biology Technology:BugLab Launches Noninvasive Biomass Monitor for Continuous, On-Line Measurements 2Accuri Cytometers Completes $13 Million Series C Financing 2Accuri Cytometers Completes $13 Million Series C Financing 3Accuri Cytometers Completes $13 Million Series C Financing 4PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call 2Unilever Extends Their GeneGo MetaCore License 2
...eviously reported initiative to establish a citywi...communities of Waukesha, Wauwatosa and Brookfield ...a are already being pitched by Cellnet, the provid...Milwaukee,s network is being built by a different ...stablished so far, the city is essentially leasing...
...student Pengpeng Zhang successfully imaged a piece... centimeter-in thickness, she and her UW-Madison c...ed thinking, the feat should be impossible because...ct electricity. , ,"After she did it, we realized,... thinner than what people normally use," says UW-...
... Third Wave Technologies has settled with a Belg...ng patents. Third Wave will license hepatitis C vi...ndisclosed financial terms. , ,The two companies, ... Wave forged a deal under which Innogenetics was a... line of products in Europe. It was Third Wave,s f...
... First Business Bank plans to launch a remote di...ne County. , ,Companies that purchased the service...over the Internet to the bank, where they would be... that First Business Bank president and COO Michae...c markets. , ,The service would eliminate trips to...
Other Biology Technology:Study explains unexpected conductivity of nanoscale silicon 2Study explains unexpected conductivity of nanoscale silicon 3
UBN-1 (C-20)
Rabbit polyclonal to Neuron navigator 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH derived from within residues 1850 to the C-terminus of Mouse Neuron
Mouse HAI-1 Ectodomain MAb (Clone 199732)
pETDuet-1 is designed for the coexpression of two target genes.
Biology Products: